undamentalytics Newsletter

Apyx Medical vs Lensar

Apyx Medical and Lensar are similar in size: $52.8m and $58.4m of revenue in their latest fiscal years. Apyx Medical grew faster (9.9% against 9.2%). Apyx Medical kept more of each dollar of sales as profit: a net margin of -21.2% against -58.7%.

Latest fiscal yearApyx MedicalAPYX, 2025LensarLNSR, 2025
Revenue $52.8m $58.4m
Revenue growth 9.9% 9.2%
Net income −$11.2m −$34.3m
Operating margin — -42.1%
Net margin -21.2% -58.7%
Return on equity -78.0% —
Free cash flow −$9.1m −$14.9m
Cash $31.7m $13.0m
Total debt $37.5m $0
Debt to equity — —
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 205 150
Market value $110m $69.6m
Price vs our value range — —
Moat score 44 (Weak) 32 (Weak)
Insider trades, 12 months 0 buys, 0 sales 0 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.